Early outcomes for rectal cancer surgery in the republic of ireland following a national centralization program

Annals of Surgical Oncology

Volumn 20, Issue 11, 2013, Pages 3414-3421

  Burke, John P ^a,b   Coffey, J Calvin ^a,c   Boyle, Emily ^a   Keane, Frank ^a   McNamara, Deborah A ^a,b  

^a Irish Association of Coloproctology   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

^c UNIVERSITY HOSPITAL LIMERICK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; FEMALE; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER; RECTUM RESECTION; SURGEON; SURGICAL MORTALITY;

ADENOCARCINOMA; AGED; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRELAND; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; SURVIVAL RATE;

EID: 84883828823     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-3131-2     Document Type: Article

References (34)

1. Kapiteijn E, Putter H, van de Velde CJ. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg. 2002;89:1142-9.
2. Kee F, Wilson RH, Harper C, Patterson CC, McCallion K, Houston RF, et al. Influence of hospital and clinician workload on survival from colorectal cancer: cohort study. BMJ. 1999;318:1381-5.
3. www.ncri.ie. Accessed 1 May 2012.
4. Boyle E, Timmons A, Al-Akash M, Kennedy AM, O'Grady H, Hill AD, et al. The management of rectal cancer in Ireland in 2007-room for improvement? Surgeon. 2011;9:179-86.
5. Archampong D, Borowski DW, Dickinson HO. Impact of surgeon volume on outcomes of rectal cancer surgery: a systematic review and meta-analysis. Surgeon. 2010;8:341-52.
6. Hogan AM, Kennelly R, Winter DC. Volume-outcome analysis in rectal cancer: a plea for enquiry, evidence and evolution. Eur J Surg Oncol. 2009;35:111-2.
7. Elferink MA, Krijnen P, Wouters MW, Lemmens VE, Jansen-Landheer ML, van de Velde CJ, et al. Variation in treatment and outcome of patients with rectal cancer by region, hospital type and volume in the Netherlands. Eur J Surg Oncol. 2010;36 Suppl 1:S74-82.
8. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-40.
9. Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373:811-20.
10. Simunovic M, Jacob S, Coates AJ, Vogt K, Moran BJ, Heald RJ, et al. Outcomes following a limited approach to radiotherapy in rectal cancer. Br J Surg. 2011;98:1483-8.
11. Taylor FG, Quirke P, Heald RJ, Moran B, Blomqvist L, Swift I, et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg. 2011;253:711-9.
12. Gagliardi G, Pucciarelli S, Asteria CR, Infantino A, Romano G, Cola B, et al. A nationwide audit of the use of radiotherapy for rectal cancer in Italy. Tech Coloproctol. 2010;14:229-35.
13. Mroczkowski P, Ortiz H, Penninckx F, Påhlman L. European quality assurance programme in rectal cancer - are we ready to launch? Colorectal Dis. 2012;14:960-6.
14. MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ. 2006;333:779.
15. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1:1479-82.
16. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2:996-9.
17. Royal College of Radiologists. Recommendations for Cross-Sectional Imaging in Cancer Management. London: Royal College of Radiologists; 2006.
18. Association of Coloproctology of Great Britain and Ireland. Guidelines for the Management of Colorectal Cancer. 3rd ed. London: Association of Coloproctology of Great Britain and Ireland; 2007.
19. Archampong D, Borowski D, Wille-Jorgensen P, Iversen LH. Workload and surgeon s specialty for outcome after colorectal cancer surgery. Cochrane Database Syst Rev. 2012;3:CD005391.
20. Killeen SD, O'Sullivan MJ, Coffey JC, Kirwan WO, Redmond HP. Provider volume and outcomes for oncological procedures. Br J Surg. 2005;92:389-402.
21. Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet. 2000;356:93-6.
22. Leonard D, Penninckx F, Fieuws S, Jouret-Mourin A, Sempoux C, Jehaes C, et al. Factors predicting the quality of total mesorectal excision for rectal cancer. Ann Surg. 2010;252:982-8.
23. Nagtegaal ID, van de Velde CJ, Marijnen CA, van Krieken JH, Quirke P; Dutch Colorectal Cancer Group; Pathology Review Committee. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol. 2005;23:9257-64.
24. Marr R, Birbeck K, Garvican J, Macklin CP, Tiffin NJ, Parsons WJ, et al. The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg. 2005;242:74-82.
25. West NP, Anderin C, Smith KJ, Holm T, Quirke P; European Extralevator Abdominoperineal Excision Study Group. Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br J Surg. 2010;97:588-99.
26. Govindarajan A, Gonen M, Weiser MR, Shia J, Temple LK, Guillem JG, et al. Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy. J Clin Oncol. 2011;29:4568-73.
27. Craven I, Crellin A, Cooper R, Melcher A, Byrne P, Sebag-Montefiore D. Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer. Br J Cancer. 2007;97:1333-7.
28. Benzoni E, Terrosu G, Intersimone D, Milan E, Chiaulon G, Bresadola V, et al. Instrumental clinical restaging, pathological evaluation, and tumor regression grading: how to assess the response to neoadjuvant chemoradiotherapy for rectal cancer. Int J Colorectal Dis. 2007;22:7-13.
29. Caudle AS, Kim HJ, Tepper JE, O'Neil BH, Lange LA, Goldberg RM, et al. Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer. Ann Surg Oncol. 2008;15:1931-6.
30. Al-Sukhni E, Milot L, Fruitman M, Beyene J, Victor JC, Schmocker S, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2012;19:2212-23.
31. Gunderson LL, Callister M, Marschke R, Young-Fadok T, Heppell J, Efron J. Stratification of rectal cancer stage for selection of postoperative chemoradiotherapy: current status. Gastrointest Cancer Res. 2008;2:25-33.
32. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638-46.
33. Srinivasaiah N, Monson JR. Radiotherapy in rectal cancer: is it time for change? A qualitative analysis of the national questionnaire survey of members of ACPGBI on preliminary CRO7 results. Colorectal Dis. 2008;10:873-8.
34. Buchholz TA, Theriault RL, Niland JC, Hughes ME, Ottesen R, Edge SB, et al. The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers. J Clin Oncol. 2006;24:361-9.